Florida Hospital College Announces Plans to Expand Campus and Programs

Posted in: // 30 Comments

Florida Hospital College of Health Sciences recently announced plans to expand its campus to accommodate more students and offer new programs in the healthcare field.
“With this new building, we are going to be able to educate and train more students in a variety of medical professions,” said Dr. David Greenlaw, president of Florida Hospital College of Health Sciences.
The new 90,000-square-foot, five-story building will feature a large multi-purpose room to host educational hospital and community events, as well as a medical simulation lab with infant, child and adult simulators. The new academic center will also house four clinical labs, five chemistry and biology labs, and a variety of other classrooms with the capability to broadcast courses to diverse geographic locations using the latest web streaming technology.
“Our students truly benefit from a hands-on learning experience,” said Kathleen Wren, Ph.D., CRNA, Chair of the Nurse Anesthesia Program at the Florida Hospital College. “This new building will enhance what we are already doing with our students. Our proximity to Florida Hospital Orlando already provides our students with a valuable clinical learning experience and by creating more programs that are in demand; we will be able to train more future medical professionals.”

In addition to the new building, the college is expanding its curriculum to offer doctorates in nurse anesthesia, physical therapy and pharmacy. The college currently has a master’s program in occupational therapy and healthcare administration in additional to a variety of associate and bachelor’s degrees ranging from nursing to diagnostic medical sonography.
Captions:
FHCollegeGroundbreaking.jpg – Florida Hospital leaders break ground on the newest academic building at the Florida Hospital College of Health Sciences that will house new graduate programs.

Orlando Health Completes Acquisition of Health Central

Posted in: Business // 43 Comments

Orlando Health’s acquisition of Health Central is complete. The $181.3 million sale became effective April 1, 2012. The acquisition creates a wholly owned subsidiary named Orlando Health Central, Inc. that will continue to operate the hospital under the Health Central name.

A 13-member board of directors consisting of representatives from Orlando Health and west Orange County has been formed to govern the new entity. The board includes 11 voting members and two non-voting members. Board members are Kathy Aber, Ann Blakeslee, John Cappleman, M.D., Becky Cherney, Samuel Davis, Jr., Jamal Hakim, M.D., Steve Harr, Randy June, Carolyn Karraker, Michael Mercado, M.D., Bob Miles, John Rinehart, and Sherrie Sitarik.
“This is an exciting time for Orlando Health and the west Orange community,” said Sherrie Sitarik, president and CEO, Orlando Health. “Our acquisition of Health Central will not only make the Orlando Health family stronger, but will enhance the quality and delivery of healthcare across our community.”
Caption: Sherrie Sitarik

Central Florida Cardiac & Vascular Institute Announces New Implant to Treat Heart Failure and Sudden

Posted in: // 150 Comments

Central Florida Cardiac & Vascular Institute of Osceola Regional Medical Center announced one of Central Florida’s first and newest Boston Scientific defibrillator implanted on February, 17, 2012. The implant of the next generation of the implantable cardioverter defibrillator (ICD) was performed by Naushad Shaik, M.D., Cardiologist and Electrophysiologist affiliated with Osceola Regional Medical Center and its Cardiac & Vascular Institute. This will also be one of the first in HCA hospitals to implant this new Boston Scientific device.

The ENERGEN DF-4 device is one of the latest Boston Scientific FDA approved collection of high-energy and smallest devices to treat heart failure and sudden cardiac death. Central Florida patients and physicians can now benefit from its enhanced therapy options, advanced battery longevity with a backup warranty of 10 years and a DF4 universal connector system in the industry’s smallest and thinnest platform.

“Creating longer-lasting devices is simply the right thing to do for the patients,” said Naushad Shaik, M.D. “It benefits those who are living longer due to advances in device therapy, those who are receiving devices earlier in their lives based on our clinical science and those who need more frequent device changes because of their clinical condition.”

Caption: Naushad Shaik, M.D.